Gheuens Sarah sold AGIO
August 4, 2026 · Form 4 insider transaction
Gheuens Sarah sold 30,000 shares of Agios Pharmaceuticals, Inc. at $30.48 per share, a transaction worth $914.4K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Footnotes
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.; The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $30.25 to $30.88. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.